Lipum
Phase 1Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases.
Founded
2010
Focus
AntibodiesBiologics
About
Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases.
Funding History
2Total raised: $12.5M
Series A$10MIndustrifondenJun 15, 2021
Seed$2.5MUmeå Biotech IncubatorJun 15, 2018
Company Info
TypePrivate
Founded2010
LocationUmeå, Sweden
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile